Plunkett Research Online: Aerovate Therapeutics Inc

AEROVATE THERAPEUTICS INC (AVTE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper.....


AEROVATE THERAPEUTICS INC

Ticker: AVTE
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 443-2400
Fax:
Address: 200 Berkeley Street
Boston, MA 2116 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Timothy NoyesCEO/Director
George EldridgeCFO/Chief Accounting Officer/Treasurer
See More
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture